Generics 424

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Clavulanic acid manufacturers

424 products found

Filters

424 products found

clavulanic acid + clavulanic acid

Tablets 200 mg + 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20305

clavulanic acid

Injection 1.2 g, 0.6 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
United Arab Emirates
GMP approvals
United Arab Emirates
Manufacturer #21193
The company’s story is one of innovation and leadership. Since the journey began in the 1980s, the goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, they have expanded the network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region.

Manufacturer usually replies in 6 days

clavulanic acid

Tablets 625 mg, 375 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
United Arab Emirates
GMP approvals
United Arab Emirates
Manufacturer #21193
The company’s story is one of innovation and leadership. Since the journey began in the 1980s, the goal has remained the same – to bring better healthcare and a brighter future to families across the globe. And in less than 40 years, they have expanded the network across the Middle East and Africa to become one of the largest pharmaceutical manufacturers in the region.

Manufacturer usually replies in 6 days

clavulanic acid + amoxicillin

Oral suspension 62.5 mg + 250 mg / 5 ml, 57 mg + 400 mg / 5 ml, 57 mg + 800 mg / 5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Chile
GMP approvals
WHO, INVIMA
Manufacturer #18571
The company produces and markets ophthalmologic products exclusively but expanded rapidly to other specialties, trying to obtain the position of one of the leaders within the international pharmaceutical industry. The company aspires to have the values of respect, loyalty, integrity, and responsibility, amongst others, prevail in all of its relationships with workers, authorities, competitors, clients, and the community at large.

Manufacturer usually replies in 5 days

clavulanic acid + amoxicillin

Tablets 125 mg + 500 mg, 875 mg + 125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Chile
GMP approvals
WHO, INVIMA
Manufacturer #18571
The company produces and markets ophthalmologic products exclusively but expanded rapidly to other specialties, trying to obtain the position of one of the leaders within the international pharmaceutical industry. The company aspires to have the values of respect, loyalty, integrity, and responsibility, amongst others, prevail in all of its relationships with workers, authorities, competitors, clients, and the community at large.

Manufacturer usually replies in 5 days

clavulanic acid + amoxicillin

Oral suspension Upon request

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17878
It was founded in the 1950s. They have a vision of building a brand that is recognized for its excellence in quality-price ratio and that improves the population's accessibility to medicines. They have reached over 8900 pharmacies with more than 80 medicinal specialties.

Manufacturer usually replies in 15 days

clavulanic acid + amoxicillin

Tablets Upon request

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17878
It was founded in the 1950s. They have a vision of building a brand that is recognized for its excellence in quality-price ratio and that improves the population's accessibility to medicines. They have reached over 8900 pharmacies with more than 80 medicinal specialties.

Manufacturer usually replies in 15 days

clavulanic acid + amoxicillin

Tablets 125 mg + 250 mg, 125 mg + 500 mg, 125 mg + 875 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20302

clavulanic acid

Tablets 500 mg+125 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19195

amoxicillin + clavulanic acid

Oral suspension 642.9 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Registered in
Portugal
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

amoxicillin + clavulanic acid

Oral suspension 500 mg + 125 mg, 875 mg + 125 mg, 1000 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Registered in
Netherlands , Spain
Available for
Licensing with supply
Manufacturer #15550

A global business leader which specializes in antibiotics, stains, and antifungals. With sustainability as its core objective, the company produces and sells intermediates and active pharmaceutical ingredients.

Manufacturer usually replies in 6 days

amoxicillin + clavulanic acid

Oral suspension 125 mg + 31.25 mg/5 ml, 250 mg + 62.5 mg/5 ml, 400 mg + 57 mg/5 ml, 600 mg + 42.9 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Registered in
Portugal , Romania
Available for
Licensing with supply
Manufacturer #15550

A global business leader which specializes in antibiotics, stains, and antifungals. With sustainability as its core objective, the company produces and sells intermediates and active pharmaceutical ingredients.

Manufacturer usually replies in 6 days

amoxicillin + clavulanic acid

Tablets, film coated 250 mg + 125 mg, 500 mg + 62.5 mg, 500 mg + 125 mg, 875 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Lebanon , Lithuania , Vietnam
Registered in
Germany , Iceland , Ireland , Netherlands , Romania , Spain , United Kingdom
Available for
Licensing with supply
Manufacturer #15550

A global business leader which specializes in antibiotics, stains, and antifungals. With sustainability as its core objective, the company produces and sells intermediates and active pharmaceutical ingredients.

Manufacturer usually replies in 6 days

amoxicillin + clavulanic acid

Tablets 500 mg + 125 mg, 250 mg + 125 mg, 875 mg + 125 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Cambodia , France , Germany , Ireland , Philippines , Poland , Sweden , United Kingdom , Vietnam
Manufacturer #20938
In the year the 2000s, it became an independent generic pharmaceutical company. It is one of the few generic pharmaceutical firms dedicated to research with the express goal of providing high-quality, low-cost healthcare to people all around the world. It all began with the goal of developing drugs to prevent, diagnose, treat, and cure diseases.

Manufacturer usually replies in 5 days

amoxicillin + clavulanic acid

Tablets 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

amoxicillin + clavulanic acid

Oral suspension 457 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

amoxicillin + clavulanic acid

Oral suspension 156.25 mg/5 ml, 312.50 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

amoxicillin + clavulanic acid

Solution for infusion 1100 mg, 2200 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

amoxicillin + clavulanic acid

Solution for injection 550 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

amoxicillin + clavulanic acid

Tablets 625 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Iraq
Manufacturer #12438
It was founded in the 1940s. One of the company’s main aims is the production of antibiotics. however, the production currently covers other therapeutic areas, including a broad portfolio of prescription, non-prescription, veterinary medicines, and dietary supplements. It sells in various international markets.

Manufacturer usually replies in 5 days

Want to view all 424 products? Create your free account today!

Clavulanic acid

Clavulanic acid is a β-lactam drug. It acts as a mechanism-based β-lactamase inhibitor. It is not an antibiotic by itself. Rather it is combined with penicillin-group antibiotics. It treats antibiotic resistance in bacteria that secrete β-lactamase, which inactivates most penicillin. Its common preparations include potassium clavulanate combined with Amoxicillin sold under the brand name amoxiclav, Augmentin, Tyclav, amongst others. Clavulanic acid was patented in 1974, but since it has been involved in preparing some of the commonly used antibiotics around the world.

Availability, Dosage, and administration.

When mixed with amoxicillin, it is sold as a tablet, a chewable, an extended-release tablet, and a suspension for oral use. The tablets, chewable tablets, and suspension are three times a day, 8 hours apart, at the start of a meal, or every 12 hours. The extended-release tablets taken with meals or snacks every 12 hours. The patients are directed to Swallow the extended-release tablets whole not to chew or crush them and if using suspension then the bottle should be mixed for making the medication properly. The quantity for the acid in both 250 mg and 500 mg is the same. The user is recommended not to substitute two 250 mg tablets for one 500 mg tablet. Also, the content of the acid is different between the 250 mg regular tablet and the 250 mg chewable tablet, so they should also not be used as substitutes.

The price of Clavulanic acid

Depending on the grade and purity, the price of one gram of Clavulanic acid can cost between USD 1 and USD 100. While the average price of 20 tablets of 100mg or 62mg is around USD 150. It is an ingredient that goes into making other medicine and is not used as an anti-biotic by itself.

How does it work?

Clavulanic acid is made up of a beta-lactam ring. These ring strongly bind to beta-lactamase at or near its active site. This hinders enzymatic activity giving protection to other beta-lactam antibiotics from beta-lactamase catalysis. The final result is an enhancement in their antibacterial effects.

Finding Clavulanic acid Manufacturers and Suppliers

The best way to find and gain access to Clavulanic acid manufacturers and Clavulanic acid suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Clavulanic acid can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Clavulanic acid to work with. You can fine-tune your search results using various filters too, letting you search for Clavulanic acid from specific countries.